Harvard Business Review

MARCH 16, 2015

Their concerns fell into three broad categories: talent, operating in a global marketplace, and regulation and legislation. Operating in a Global Marketplace. Eight of the CEOs pointed to the challenges of operating in a fast-paced global marketplace. Talent pipelines were also a concern. Currency really had a big effect.”

CEO 8

CEO Stephenson Pharmaceuticals Globalization 8

Harvard Business Review

MARCH 2, 2012

As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. economy, expands America's global trade, and attracts foreign companies to base operations in the U.S.

Competitive Advantage 12

Competitive Advantage Globalization Development Intellectual Capital 12

Harvard Business Review

MARCH 6, 2015

Apple has a similar split , with 60% of its 2014 fourth-quarter revenue accounted for by international markets. American companies with strong performance in international markets frequently have a founder or a prominent executive on their team who is either from a foreign country or is a first-generation American.

Company 8

Company Globalization Software Wireless 8

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. Dr Reddy's plan is to leverage Chirotech's scientific capabilities to optimize drug development processes, thus lowering manufacturing costs and speeding time-to-market. Cambridge, U.K. facility in Cambridge Science Park.

Globalization 9

Globalization Innovation Decentralization Chemicals 9

Harvard Business Review

JULY 7, 2011

Many of the best leaders and managers in the business world operate from the Pleaser power style. When they are operating from their strengths, Pleasers can become the glue that holds a positive corporate culture together. Roger, a vice president of sales and marketing in the pharmaceutical industry, was one such Pleaser.

Rogers 14

Rogers Morale Long-term Pharmaceuticals 14

Harvard Business Review

NOVEMBER 24, 2015

The most common source of joint value is economies of scale , which allow for a reduction in the costs of either production or back-office operations. To make a combination successful, you need to engineer the economies of scale carefully to target the potential source of joint value.

Pharmaceuticals 8

Pharmaceuticals Cost Airlines Productivity 8

Harvard Business Review

MARCH 28, 2012

The Swiss pharmaceutical giant Roche is nothing if not determined in its quest to acquire Illumina, the San Diego-based leader in genetic-sequencing equipment. This means they're buying drugs that could be similar to others already on or coming soon to the market. billion tender offer directly to shareholders.

Innovation 12

Innovation Company Biotechnology CFO 12

Harvard Business Review

JANUARY 31, 2013

First we see major shifts in demand: developing economies such as China and India are morphing from the world's source of low-cost manufacturing capacity to the world's best market opportunities. Pharmaceutical companies are mastering bio-engineering techniques that will help develop personalized medicines.

Globalization 9

Globalization Supply Chain Pharmaceuticals McKinsey 9

Harvard Business Review

JUNE 16, 2016

To understand the nature of the problem, let’s look at how penicillin was brought to market. The key to making these organizations work is integrating the work of discovery-driven researchers, applied scientists, and engineers in the private sector. “But here, we can operate within the time frame of the next coffee break.”

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Harvard Business Review

APRIL 15, 2015

By 1973, there were 3,000 industrial robots in operation. million industrial robots are in use or available in various industries including automotive, electronics, rubber and plastics, cosmetics, pharmaceutical, and food and beverage. Their market value is $9.5 It was precise, but not necessarily elegant. Today, more than 1.3

Definition 8

Definition Ethics Industry Automotive 8

Harvard Business Review

FEBRUARY 20, 2014

But an awful lot of these jobs command very high-wages in law, finance, accounting, consulting, advertising, engineering, design, software, healthcare, scientific research, architecture, entertainment, hospitality, and many other areas. True, emerging market countries are getting better at what they do, and even Europe is on the upswing.

Intellectual Capital 8

Intellectual Capital Magazine Pharmaceuticals Creativity 8

Harvard Business Review

JULY 16, 2013

pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., aerospace & defense, construction & engineering, industrial conglomerates, professional services, textiles); IT & Telecommunications (e.g., food, beverage & tobacco, household and personal products); Energy & Utilities (e.g.,

Telecommunications 8

Telecommunications Biotechnology Health Care Real Estate 8

Harvard Business Review

OCTOBER 24, 2014

In addressing the billion-dollar adherence problem, Vitality (since acquired by NANTHEALTH ) considered the interests of the players in the diverse ecosystem, including pharmaceutical companies, retail pharmacies, and health care providers. Operations. Engineering. These may involve new areas for the company (e.g.,

Productivity 8

Productivity Products Company Engineering 8

Harvard Business Review

SEPTEMBER 5, 2016

Operating decisions are almost entirely decentralized. Each branch makes its own loan decisions, sets its own pricing on loans and deposits, controls its own marketing budget, runs its own website (on a shared platform), and serves all customer segments — from individuals to multinationals — within its catchment area.

Cost 8

Cost Bureaucracy GDP Management 8

Harvard Business Review

NOVEMBER 21, 2013

For many years, beginning in 1942, Premarin was the only hormone replacement therapy drug on the market derived from a natural source. Wyeth, a pharmaceutical acquired by Pfizer in 2009, was the sole supplier of Premarin. Unlike with patents, it is perfectly legal to reverse engineer and copy a trade secret.

Intangible Assets 8

Intangible Assets Merchandising Innovation Pharmaceuticals 8

Harvard Business Review

JULY 12, 2011

Boston Scientific a few years back launched a secret project to reverse-engineer the technology of its single-source supplier of coronary stents. The long-standing exclusive arrangement between Xerox and Fuji Photo Film in Japan is one example; pharmaceutical licensing across markets is another. It can work, but it's rare.

Management 11

Management Airlines How To Pharmaceuticals 11

Harvard Business Review

SEPTEMBER 11, 2014

That means new technologies and new competitors are hitting the market at an unprecedented rate. Finally, industries in the upper-right quadrant — such as software, pharmaceuticals, and medical equipment — face high uncertainty in both demand and technology. To illustrate this, consider that patent applications in the U.S.

Uncertainty 22

Uncertainty Industry Bottom-up Technology 22

Harvard Business Review

JULY 20, 2017

This is the challenge for all kinds of disruptors, whether in the auto industry, pharmaceuticals, service industries, or healthcare. DNA genetic testing company 23andMe fell behind on its communications with the FDA, resulting in a temporary ban on marketing the company’s personal genetic screening services to the public.

Innovation 13

Innovation Productivity Products Venture Capitalist 13

Harvard Business Review

JUNE 30, 2014

Places full of highly mobile and in-demand workers operate more democratically. In the words of Empson and Alvehus they have gained “legitimacy to lead through market success.” In today’s knowledge-based and highly-automated enterprises, companies look for the cleverest and most capable people they can find. How do they do that?

Politics 8

Politics Pharmaceuticals Consultative Consensus 8